McKesson (MCK) DIvidends Date & History

Key Takeaways

• MCK pays a modest dividend yield of roughly 0.4%, well below the broader healthcare sector average.
• The company has raised its dividend for 17–18 consecutive years, supported by strong and growing free cash flow.
• McKesson's dividend payout ratio is very low at roughly 9–10% of earnings, leaving ample room for future increases.
• Its five-year dividend growth rate of roughly 13–15% ranks among the fastest in the healthcare distribution industry.
• Dividends are paid quarterly, with the most recent increase lifting the quarterly payment to $0.94 per share.
• The stock is better suited to dividend growth investors than to income-focused investors seeking high current yield.

Dividend Overview

McKesson Corporation (MCK), one of the largest pharmaceutical and medical supply distributors in the United States, maintains a consistent but deliberately modest dividend. The company pays its dividend on a quarterly basis, and its most recent increase brought the quarterly payment to $0.94 per share, or roughly $3.76 per share on an annualized basis. At current share prices, this translates to a dividend yield of only about 0.4%, which is low in absolute terms and considerably below the average for the healthcare sector.

McKesson is best characterized not as a high-yield stock but as a dividend growth stock. The company prioritizes reinvesting its substantial free cash flow into the business and share repurchases, while still rewarding shareholders with steadily rising dividends. This conservative-yield, high-growth profile makes MCK a distinctive holding for investors who value long-term payout growth over immediate income.

Dividend History and Growth

McKesson has built a reliable record of annual dividend increases, having raised its payout for roughly 17–18 consecutive years. The pace of that growth has been notable: over the past five years, the dividend has compounded at a rate of roughly 13–15% annually, placing it near the top of its industry.

Recent quarterly payments illustrate this trajectory. The dividend rose from $0.62 per share to $0.71, then to $0.82, and most recently to $0.94 per share. Annual dividends per share have climbed from about $1.67 in fiscal 2021 to roughly $2.75 in fiscal 2025, with further increases already declared for subsequent periods. This steady upward path reflects management's confidence in the durability of McKesson's cash generation and its long-term strategy of delivering consistent, predictable increases to shareholders.

Dividend Sustainability and Payout Ratio

McKesson's dividend appears highly sustainable by conventional measures. The payout ratio, which compares dividends to earnings, stands at only about 9–10%, meaning the company distributes a small fraction of its profits as dividends. When measured against free cash flow (the cash a company generates after funding operations and capital spending), the dividend cash payout ratio is even lower, at roughly 6–8%.

This wide margin of safety is a key strength. Because McKesson retains the overwhelming majority of its earnings, it has substantial flexibility to continue raising the dividend even if earnings face temporary pressure. The company also maintains a solid balance sheet for a distributor, an industry that typically operates on thin margins and high revenue volume. Combined with disciplined share repurchases, this conservative payout structure indicates the dividend is well covered and unlikely to be reduced under normal operating conditions.

Dividend Compared to Industry Peers

Within the healthcare distribution sector, McKesson's yield is the lowest among the major players. Peer Cardinal Health (CAH) and Cencora (COR) generally offer dividend yields that are meaningfully higher than McKesson's roughly 0.4%. The industry median yield tends to sit around 2% or more.

However, what McKesson lacks in current yield it compensates for with superior dividend growth. Its five-year dividend growth rate of roughly 13–15% outpaces many peers, and its unusually low payout ratio gives it more capacity to sustain rapid increases over time. Investors comparing these stocks are effectively weighing a smaller current payment against a faster-growing one. For those focused on the trajectory of their income stream rather than today's yield, MCK stands out despite its smaller headline payout.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is particularly useful for identifying dividend stocks, income-focused investments, trending stocks, and breakout candidates far more efficiently than manual screening. For investors researching names like McKesson and its peers, the AI Screener offers a streamlined way to compare yield, growth, and valuation across an entire sector in a single view.

Is This Stock Attractive for Dividend Investors?

McKesson is likely to appeal most to dividend growth investors and long-term, total-return-oriented investors rather than to those who depend on current income. Its yield of around 0.4% provides minimal immediate cash flow, which makes it a poor fit for conservative or income-focused investors seeking a dependable stream of payments today.

On the other hand, the combination of an exceptionally low payout ratio, strong free cash flow, and a long streak of double-digit-percentage dividend increases gives MCK a compelling growth profile. Investors with a multi-year horizon may benefit from a rising income stream alongside share repurchases that support shareholder returns. The trade-off is clear: this is a dividend growth story, not a dividend yield story. Investors who prioritize the rate at which their income grows over the starting yield may find McKesson's dividend profile attractive, while those needing substantial current income will likely look elsewhere.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations